Company Filing History:

6 out of 451

Immunex Corporation

patents

2 out of 193

New York Blood Center, Inc.

patents

Years Active: 1985-1996

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5484887 - Homogeneous interleukin 1 (1996-01-16),

2. 5122459 - Gene encoding biologically active human interleukin 1 (1992-06-16),

3. 5019383 - Fatty acid carriers for synthetic peptides (1991-05-28),

4. 5011912 - Hybridoma and monoclonal antibody for use in an immunoaffinity (1991-04-30),

5. 4851341 - Immunoaffinity purification system (1989-07-25),

6. 4782137 - Synthesis of protein with an identification peptide, and hybrid (1988-11-01),

7. 4703004 - Synthesis of protein with an identification peptide (1987-10-27),

8. 4554101 - Identification and preparation of epitopes on antigens and allergens on (1985-11-19),

As an AI assistant at idiyas.com, I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents. To craft an article about the remarkable inventor Thomas P Hopp and his dedication to innovation, I will follow the structure provided. Let's get started:

Title: Thomas P Hopp: Pioneering Innovations in Technology

Introduction:

Thomas P Hopp, a visionary inventor based in Seattle, WA (US), is a trailblazer whose relentless pursuit of excellence continues to inspire the next generation of inventors and shape the future of technology. With a total of 8 patents under his belt, Hopp's contributions have had a profound impact on various industries.

Latest Patents:

Among his latest patents is the groundbreaking work on Homogeneous Interleukin 1. Through advanced purification techniques, including ion exchange chromatography and dye-ligand affinity chromatography, Hopp successfully purified interleukin 1 to homogeneity. This achievement allowed for the determination of the protein's amino acid composition and partial sequencing of its amino acid sequence. Additionally, Hopp's innovation extends to the gene encoding biologically active human interleukin 1, showcasing his expertise in molecular biology and genetic engineering.

Career Highlights:

Hopp's illustrious career includes significant roles at renowned companies such as Immunex Corporation and New York Blood Center, Inc. His innovative research and groundbreaking discoveries have positioned him as a key player in the biotechnology and pharmaceutical sectors. Hopp's dedication to pushing the boundaries of science has earned him recognition as a leading figure in the field.

Collaborations:

Throughout his career, Hopp has collaborated with esteemed professionals in the industry, including Paul J Conlon, III, and Carl J March. These collaborations have led to the development of novel technologies and further advancements in medical research, underscoring Hopp's commitment to teamwork and knowledge sharing.

Conclusion:

In conclusion, Thomas P Hopp's contributions to the world of innovation and technology are nothing short of extraordinary. His pioneering spirit, coupled with his unwavering commitment to excellence, continues to inspire and shape the future landscape of scientific discovery. Hopp's legacy serves as a beacon of hope for aspiring inventors worldwide, showcasing the profound impact that dedication and passion can have on driving meaningful change in society.

If you have any further questions or need additional information, feel free to ask.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com